Formoterol: all 179 studies that test it

Page 1 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)Not yet recruitingNCT07721922Phase 4
• A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationRecruitingNCT07073950Phase 4
• Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary ComplicationsRecruitingNCT06865040Not applicable
• Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEctionNot yet recruitingNCT06597682Not applicable
• Anti-Inflammatory Reliever South AfricaRecruitingNCT06429475Phase 3
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRecruitingNCT06283966Phase 3
• Expertise Asthma COPD Program with Digital SupportRecruitingNCT05831566Phase 3
• A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)CompletedNCT05755906Phase 3Results posted
• A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidCompletedNCT05292586Phase 3Results posted
• A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)CompletedNCT05202262Phase 3Results posted
• Functional Respiratory Imaging Study (DARWiIN)CompletedNCT04876677Phase 3Results posted
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)CompletedNCT04609904Phase 3Results posted
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)CompletedNCT04609878Phase 3Results posted
• ARrest RESpiraTory Failure From PNEUMONIATerminatedNCT04193878Phase 3Results posted
• Personalized Treatment Algorithms for Difficult-to-treat AsthmaCompletedNCT04179461Phase 2Results posted
• Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.CompletedNCT04078126Phase 3Results posted
• A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPDCompletedNCT03836677Phase 3Results posted
• Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®CompletedNCT03262012Phase 3Results posted
• Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT03162055Phase 3Results posted
• Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD PatientsCompletedNCT03022097Phase 3Results posted
• Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic PatientsCompletedNCT03015259Phase 3Results posted
• AMPLIFY - D6571C00001 Duaklir USA Phase III StudyCompletedNCT02796677Phase 3Results posted
• Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)CompletedNCT02796651Phase 2Results posted
• Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDCompletedNCT02766608Phase 3Results posted
• Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPDTerminatedNCT02685293Phase 3Results posted
• Clinical Study to Evaluate Z7200 Pharmacokinetics ProfileCompletedNCT02631941Phase 1Results posted
• Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT02536508Phase 3Results posted
• A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)CompletedNCT02497001Phase 3Results posted
• Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic ParticipantsCompletedNCT02495168Phase 3Results posted
• Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)CompletedNCT02465567Phase 3Results posted
• Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD PatientsCompletedNCT02424344Phase 4Results posted
• 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDICompletedNCT02347085Phase 3Results posted
• 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and PlaceboCompletedNCT02347072Phase 3Results posted
• A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02345161Phase 3Results posted
• Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPDCompletedNCT02343458Phase 3Results posted
• COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder InhalersCompletedNCT02291016Not applicableResults posted
• A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy VolunteersCompletedNCT02237508Phase 1Results posted
• Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic PatientsCompletedNCT02227394Phase 2Results posted
• Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02196077Phase 2Results posted
• Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPDCompletedNCT01917331Phase 3Results posted
• Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01908140Phase 3Results posted
• Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)CompletedNCT01854658Phase 3Results posted
• Study of Safety of Foradil in Patients With Persistent AsthmaTerminatedNCT01845025Phase 4Results posted
• Effect of Symbicort ® on GR in Sputum in COPDCompletedNCT01787097Phase 4Results posted
• LIPS-B: Lung Injury Prevention Study With Budesonide and BetaCompletedNCT01783821Phase 2Results posted
• Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus PlaceboTerminatedNCT01760304Phase 4Results posted
• Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate AsthmaCompletedNCT01641081Phase 2Results posted
• Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01572792Phase 3Results posted
• Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)CompletedNCT01488019Phase 4Results posted
• Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose CombinationCompletedNCT01462942Phase 3Results posted
• Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01437540Phase 3Results posted
• Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01437397Phase 3Results posted
• Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary DiseaseCompletedNCT01391559Not applicableResults posted
• A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)CompletedNCT01258803Phase 2Results posted
• Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.CompletedNCT01194479Not applicableResults posted
• A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in AsthmaCompletedNCT01167010Phase 3Results posted
• Sub-Sensitivity to Long-Acting Bronchodilators (LABA)CompletedNCT01117116Not applicableResults posted
• Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaTerminatedNCT01070888Phase 4Results posted
• Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®CompletedNCT01048333Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01047553Phase 3Results posted
• Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma PatientsCompletedNCT00989833Phase 2Results posted
• Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00909779Phase 3Results posted
• A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic PatientsTerminatedNCT00819637Phase 4Results posted
• Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00773786Phase 4Results posted
• Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent AsthmaCompletedNCT00746330Phase 2Results posted
• Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease PatientsCompletedNCT00680056Phase 4Results posted
• Dose-response of Inhaled Formoterol Using Methacholine Challenge as a BioassayCompletedNCT00643578Not applicableResults posted
• Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EUCompletedNCT00628862Phase 3Results posted
• Aclidinium/Formoterol Fixed Combination Dose Finding StudyCompletedNCT00626522Phase 2Results posted
• A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric SubjectsCompletedNCT00583947Phase 2Results posted
• Local Phase 4 Pan-European SMART StudyCompletedNCT00463866Phase 4Results posted
• Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00424528Phase 4Results posted
• A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDCompletedNCT00419744Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)CompletedNCT00383552Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)CompletedNCT00383240Phase 3Results posted
• Effect of Symbicort on GR Localisation in AsthmaCompletedNCT00159263Not applicableResults posted
• Extrafine ICS/LABA Versus As-Needed SABA for Small Airway Dysfunction in Symptomatic Patients With Preserved SpirometryCompletedNCT07809555Phase 4
• Budesonide/Formoterol Inhalation Powder in Adults With AsthmaCompletedNCT07790159Phase 3
• Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover StudyCompletedNCT06905483Phase 4
• U-LABA/ICS Effects on Exercise Performance, FormoterolCompletedNCT06105671Not applicable
• A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT06067828Phase 3
• Cardiovascular Consequences of Inhaled Short-acting Beta-agonist UseCompletedNCT06027606Phase 1
• Beta2-adrenergic System and TrainingStatus unknownNCT04616261Not applicable
• Three Treatment of Chronic Obstructive Pulmonary Disease PatientsCompletedNCT04520230Phase 4
• A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal BlockCompletedNCT04494321Phase 1
• As-needed Budesonide/Formoterol Turbuhaler in Stepping Down PeriodCompletedNCT04215848Phase 3
• The Efficacy of Budesonide/Formoterol in Cough Variant AsthmaStatus unknownNCT04171180Phase 4
• Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy VolunteersStatus unknownNCT04137029Not applicable
• Beta2-adrenergic Agonism and Muscle RemodellingStatus unknownNCT03565302Not applicable
• Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 YearsStatus unknownNCT03387241Phase 3
• Functional Respiratory Imaging Study (FRI)CompletedNCT03268226Phase 3
• The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in SmokersCompletedNCT03104634Phase 3
• Salvational Intervention for Reducing AECOPD Under Severe Air PollutionCompletedNCT03083067Not applicable
• Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedNCT03073057Phase 1
• Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination TreatmentCompletedNCT02988869Phase 4
• Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD PatientsCompletedNCT02975843Phase 1
• Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC TrialCompletedNCT02972476Phase 4
• A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal BlockCompletedNCT02850484Phase 1
• Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down AsthmaCompletedNCT02725242Phase 3
• Assessment of Airway Responsiveness and Treatment Efficacy in AsthmaticsStatus unknownNCT02574975Phase 4

← Formoterol overview